SCIENTIFIC POINT OF VIEW Rasmus Damsgaard, MD, PhD; FIS Medical - - PowerPoint PPT Presentation

scientific point of view
SMART_READER_LITE
LIVE PREVIEW

SCIENTIFIC POINT OF VIEW Rasmus Damsgaard, MD, PhD; FIS Medical - - PowerPoint PPT Presentation

1 RATIONEL PANIC FROM A SCIENTIFIC POINT OF VIEW Rasmus Damsgaard, MD, PhD; FIS Medical Committee S-EPO (erythropoeitin) 2 The production of Red Blood Cells 3 FIS Blood Testing 4 FIS before Bengt Saltin FIS after Bengt Saltin 17 17


slide-1
SLIDE 1

Rasmus Damsgaard, MD, PhD; FIS Medical Committee

RATIONEL PANIC – FROM A SCIENTIFIC POINT OF VIEW

1

slide-2
SLIDE 2

S-EPO (erythropoeitin)

2

slide-3
SLIDE 3

The production of Red Blood Cells

3

slide-4
SLIDE 4

FIS Blood Testing

13 14 15 16 17 1987/1988 1989 1994 1995 1996 1997 1998 1999 2001/2002 Male Female

FIS before Bengt Saltin FIS after Bengt Saltin

13 14 15 16 17 1987/1988 1989 1994 1995 1996 1997 1998 1999 2001/2002 Male Female

Morkeberg J, Saltin B, Belhage B, Damsgaard R. Blood profiles in elite cross- country skiers: a 6-year follow-up. Scand J Med Sci Sports. 2008 Feb 17

4

slide-5
SLIDE 5

Blood Profiles

Normal EPO positive

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

23-Nov-01 27-Nov-01 1 4-Dec-01 1 6-Dec-01 05-Jan-02 1 8/01 /02

0.5 1 1.5 2 2.5 3

5

slide-6
SLIDE 6

Blood Profiles

Normal EPO positive

6

slide-7
SLIDE 7

Erythropoietin

7

slide-8
SLIDE 8

The EPO Test (Lasne F

, de Ceaurriz J. Nature 2000)

8

Neo- recormon Eprex Control Subject Early EPO inj. Later EPO inj. TdF Cyclist 1998

slide-9
SLIDE 9

EPO Profile

9

slide-10
SLIDE 10

EPO Profile

10

slide-11
SLIDE 11

Previous EPO technical document

11

slide-12
SLIDE 12

Olympic Athlete (ref. Süddeutschen Zeitung)

  • Blood Collection Period: 2000-2010
  • No. of blood screenings >100
  • No. of Urine EPO = unknown but many
  • Abnormal blood profile
  • No. of positive EPO tests = 0

12

slide-13
SLIDE 13

Blood Profile Results (ref. Süddeutschen Zeitung)

Normal Olympic Athlete

FACTS

  • Haemoglobin variation <5%
  • Reticulocytes range 1%-3.5%
  • Withdrawing of 1300 mL blood =

reticulocytes >2.5%

  • EPO injections >4000 IE three days a

week = reticulocytes >2.5%

  • Extensive but unknown no. of negative

EPO tests in- and Out-Of-Competition DOPING CONCLUSION

  • EPO in large amount or a

combination of EPO and blood transfusion with constant hemodilution (saline or albumin) for10 consecutive years including the Olympic Games, World Championships and World Series without being caught…

13

slide-14
SLIDE 14

Olympic Athlete (Medical Condition)

  • Benign

Reticulocytosis

14

slide-15
SLIDE 15

Clenbuterol

 Beta2agonist (asthma medication)  Clenbuterol may increase fat free mass in some animals  Clenbuterol is not approved for human or animal treatment  Clenbuterol is, however, found in meat from livestock (11% in Mexico – an

increase of 6%)

 There is no scientific evidence that Clenbuterol is anabolic in humans  Clenbuterol is found in some nutritional supplements without being declared  A number athletes have been tested positive for low concentrations of

clenbuterol especially after competing in Mexico and China

 A number of tourists returning from Mexico and China have been found with

Clenbuterol in their urine. Contents that were not present upon departure.

15

slide-16
SLIDE 16

Clenbuterol

 One of the largest food poisoning cases involving

clenbuterol happened in Shanghai in September 2006, when 336 people were hospitalized after eating pig meat or organs contaminated with the additive, China Daily

 Many more cases of recent clenbuterol poisoning is

published

16

slide-17
SLIDE 17

Clenbuterol (ref. Cyclingnews.com)

Dimitrij OVTCHAROV’s

17

slide-18
SLIDE 18

Two Cases of Clenbuterol (ref. Cyclingnews.com, Sport

Federations, various News papers)

 Same International Federation  Same competition  Same hotel  Same food  Same time

18

slide-19
SLIDE 19

Two Cases of Clenbuterol

 Positive test 25 April 2010  8 October 2010

sanctioned 1 year

 Positive test 25 April 2010  Notified late September

2010

 21 March acquitted from

the use of Clenbuterol

 8 June, decision appealed

by WADA

Athlete 1 (5 months) Athlete 2 (11 months)

19

slide-20
SLIDE 20
  • The case with the table tennis player, Dimitrij

Otcharov, who was tested positive with a similar content of Clenbuterol was acquitted and his case was NOT APPEALED.

PS.

20

slide-21
SLIDE 21

Thank You

21